HALO logo
halo search icon
CSL
CSL Limited

CSL · CSL Limited

169.50

AUD
-1.71 (-0.999%)
10/09/2026 04:15:56 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$82.16B

PE

15.30

EV/EBITDA

9.5

DIV Yield

3.5%

Franking

0%

MQV Rating

3Neutral

As at 10/09/2026 04:15:56 PM

Price Chart

Description

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

  • All-Companies
  • All-Consensus
  • ALL-Recommendations
  • ASR Trading Report - All
  • EMA 125 Breakup
  • Fakey Shakey - Short
  • GROWTH AUS
  • HALO 100
  • HALO 200
  • HALO 50
  • HALO Growth
  • HALO Ords
  • HALO Price Momentum
  • Hammer Bearish (Realtime)

Key Fundamentals

EPS 3 yr Growth

-215.00%

EBITDA Margin

32.20%

Operating Cashflow

$3,512m

Free Cash Flow Return

12.80%

ROIC

-9.40%

Interest Coverage

11.70

Quick Ratio

1.00

Performance

52 weeks range

Low 90 - 222.47

Trade Value (12mth)

US$37,819,145.00

1 week

-1.52%

1 month

23.67%

YTD

-0.44%

1 year

-16.27%

All time high

342.75

Additional Data

Shares Outstanding (Fully Diluted)

479m

HALO Sector

Healthcare

Next Company Report Date

17-Aug-27

Next Ex Dividend Date

09-Sep-26

Next Dividend Pay Date

02-Oct-26

Reporting Currency

USD

Short Sell (% of issue)

1.46

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Neutral

Garp

Strong

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
27 August 26ASXD
27 August 26ASXD
27 August 26ASXD
27 August 26ASXD
27 August 26ASXD

Key Stakeholders

NameTitle
Brian Anthony McNameeIndividual
Robert Andrew CuthbertsonIndividual
Gordon NaylorIndividual
Paul McKenzieIndividual
Joy Carolyn LintonIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of CSL Limited (CSL:ASX)?
Halo FAQ
The current share price of CSL Limited (CSL:ASX) is AUD$169.50.
2
What is the 52-week high share price for CSL Limited (CSL:ASX)?
Halo FAQ
The 52-week high share price for CSL Limited (CSL:ASX) is AUD$222.47.
3
What is the 52-week low share price for CSL Limited (CSL:ASX)?
Halo FAQ
The 52-week low share price for CSL Limited (CSL:ASX) is AUD$90.00.
4
What is the dividend yield for CSL Limited (CSL:ASX)?
Halo FAQ
The current TTM dividend payout for CSL Limited (CSL:ASX) is 3.50.
5
What was CSL Limited (CSL:ASX) last dividend payment?
Halo FAQ
The last dividend payment of CSL Limited (CSL:ASX) is AUD$2.25.
6
What is the franking level for CSL Limited (CSL:ASX)?
Halo FAQ
CSL Limited (CSL:ASX) has a franking level of 0.00%.
7
In which sector is CSL Limited (CSL:ASX) classified?
Halo FAQ
CSL Limited (CSL:ASX) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for CSL Limited (CSL:ASX)?
Halo FAQ
The current P/E ratio for CSL Limited (CSL:ASX) is 15.30.